×

Dr. Aslam Pathan

Founder

Dr. Aslam leads the Author Gate editorial team. He has overall responsibility for setting the editorial strategy and for the policy and practices governing the selection and publication process for the Author Gate.
Dr. Aslam is currently Head of the Scientific Research Unit and faculty of Pharmacology at the College of Medicine at Shaqra, Saudi Arabia. He received his D. Pharm degree from the Maharashtra State Board of Technical Education, Mumbai, India; a Bachelor’s degree in Pharmacy from the University of Pune, India; a Master’s degree in Pharmacology; and a Ph.D. in Pharmacy/Pharmacology from North Maharashtra University, Jalgaon, India. He earned a full-time Ph.D. degree under the Maulana Azad National Fellowship awarded by the University Grants Commission, New Delhi, India. He has published over 75 research articles in the world’s top reputable journals.
His Ph.D. degree is verified by the World Education Services, Canada, and issued the ‘International Academic Qualification’ badge. He bagged all his academic degrees in the first-class honor.

-

-

Dr. Aslam Pathan honored and appreciated for the esteemed support as ‘Research Day-2023 Coordinator’ organized by the College of Medicine at Shaqra University, Saudi Arabia on 04 May 2023.

-

-

Dr. Aslam Pathan honored and appreciated as Head of Scientific Research Unit for the contribution to NCAAA full accreditation of the MBBS program (20 May 2025).

-

-

Dr. Aslam Pathan honored and appreciated for the esteemed support as ‘Research Day-2022 Coordinator’ organized by the College of Medicine at Shaqra University, Saudi Arabia on 30 March 2022.

-

-

Dr. Aslam Pathan honored and appreciated for the academic performance (Best Academic Staff in the Basic Medical Sciences Department) by the Respected Dean, College of Medicine, Shaqra University, Saudi Arabia. (academic year 2016-17)

-

-

Dr. Aslam Pathan as a Co-Cordinator of Quality and Accereditation Unit (NCAAA) from 2021 to 2023 appreciating the the Respected Dean, College of Medicine, Shaqra University, Saudi Arabia for his leadership and getting NCAAA accreditation to the Medicine Program.

-

-

Dr. Aslam Pathan as a Head of Scientific Research Unit, briefing the achievemnets of 'Research Unit' in presence administrations of College of Medicine, Shaqra University.

-

-

Dr. Aslam Pathan honored and appreciated for the academic performance (Best Academic Staff in the Basic Medical Sciences Department) by the Respected Dean, College of Medicine, Shaqra University, Saudi Arabia. (academic year 2018-19)

-

-

Dr. Aslam Pathan honored and appreciated for the academic performance (Best Academic Staff in the Basic Medical Sciences Department) by the Respected Dean, College of Medicine, Shaqra University, Saudi Arabia. (academic year 2022-23)

-

-

Dr. Aslam Pathan honored and appreciated for the publication in the high-ranking journal for the academic year 2023-2024.

Publications of Dr. Aslam Pathan

 

  1. Almalki EM, Altaweel KW, Pathan AR, Alkhaldi M, Maswood MM, Brema I, Alsaheel AY, Almalk MH. Polyautoimmunity in adults and children with type 1 diabetes mellitus: findings from a Saudi cohort. Sudan J Paed. 2025; 25(1): 13-23. Click here
  2. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019. Nature Communications. Click here
  3. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. The Lancet Respiratory Medicine. Click here
  4. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. The Lancet. Click here
  5. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. Click here
  6. Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021. The Lancet HIV. Click here
  7. Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021. The Lancet Infectious Diseases. Click here
  8. Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021. The Lancet, Volume 403, Issue 10440, 2204 – 2256. Click here
  9. Pathan A. Aamir M. Misuse of Alprazolam as ‘kutta goli’ among the youth and school children in the Malegaon city of India. NeuroPharmac Journal. 2024;9(1):01-05. Click here
  10. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Click here
  11. Pathan A. Limitations of Alzheimer’s Disease Medications. NeuroPharmac Journal. 2023;8(3):11-17. Click here
  12. Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023 Sep 25;5(10):e594-e610. Click here
  13. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019. EClinicalMedicine. 2023 Sep 9;64:102193. Click here
  14. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021. The Lancet Haematology. Click here
  15. Pathan A. Stroke and migraine are leading neurological conditions on a global scale. NeuroPharmac Journal. 2023; (08): 1-2. Click here
  16. Pathan A, Logade N, Khan F. Neurological adverse effects after SARS-CoV-2 vaccinations: Etiology should be warranted. NeuroPharmac Journal. 2023; (08): 1-5. Click here
  17. Farag M, Pathan A, Aldoij N. Interaction between anti-COVID compounds across spike protein subunits influences their inhibition potential. Ann. Phytomed. 2023; 12(1):1-8. Click here
  18. Farag M, Pathan A, Aldoij N. Molecular docking analysis of ten plant products for the inhibition of spike glycoprotein and prospective use as anti-COVID compounds. Ann. Phytomed. 2022;11(2):302-308. Click here
  19. Alenazi F, Pathan A. Neuropharmacology of Levetiracetam as Anti-epileptic Medication. NeuroPharmac Journal. 2022; (12): 1-6. Click here
  20. AE Peden, P Cullen, KL Francis, H Moeller, MM Peden, Pathan A. Adolescent Transport and Unintentional Injuries Collaborators. Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(8):e657-e669. Click here
  21. Farag M, Pathan A. Aldoaij N. Literature review of 10 plants products for their anti-inflammatory, antioxidant, immunomodulatory, and antiviral properties. NeuroPharmac Journal. 2021; (12): 241-247. Click here
  22. Pathan A. Neurological complications and COVID-19: A literature review NeuroPharmac Journal. 2021;(04): 142-144. Click here
  23. Alshahrani A, Jamal Y, Almarshad F, Pathan A, Arif J. Correlation of COVID-19 with Parkinson’s disease and life expectancy indicates female population predominance in future. Annals of Phytomedicine-an International Journal; 10(1): S13-S21, 2021. Click here
  24. Bilal Ahamad Paray, Aqeel Ahmad, Javed Masood Khan, Faisal Taufiq, Aslam Pathan, Ajamaluddin Malik, Mohammad Z. Ahmed, The role of the multifunctional antimicrobial peptide melittin in gene delivery, Drug Discovery Today, 2021, https://pubmed.ncbi.nlm.nih.gov/33450177/
  25. Pathan A. Alshahrani A. Almarshad F. COVID-19 in the Shaqra, Saudi Arabia: prevalence and prevention strategies. NeuroPharmac J. 2020; 5(3): 131- 134. https://doi.org/10.37881/1.531
  26. Almujalli AA, Almatrafi AA, Aldael AA, Almojali HA, Almujalli AI, Pathan A. Knowledge, attitude, and practice about myopia in school students in Marat city of Saudi Arabia. J Family Med Prim Care 2020;9:3277-80 https://pubmed.ncbi.nlm.nih.gov/33102283/
  27. Pathan A. Lamotrigine and Phenytoin indicated for epilepsy recalled by the manufacturer in America. NeuroPharmac J. 2020;5(1):118-120. https://doi.org/10.37881/1.513
  28. Pathan A. Urgent health challenges for the next decade 2030: World Health Organization. NeuroPharmac J. 2020;5(1):113-117. https://doi.org/10.37881/1.512
  29. Pathan A. Current off-label Pharmacotherapeutics in the management of novel coronavirus disease (COVID-19). NeuroPharmac J. 2020;5(1):108-112. https://doi.org/10.37881/1.511
  30. Pathan A. Top Pharma companies not following current good manufacturing processes: Angiotensin II receptor blockers with carcinogenic impurities: A threat to global public health. NeuroPharmac J. 2019;4(3):105-107. https://doi.org/10.37881/1.432
  31. Pathan A. FDA recalled Ranitidine: What about the consumers who ate Ranitidine with carcinogenic impurity by paying to Pharma companies? NeuroPharmac J. 2019; 4(3): 103-104. https://doi.org/10.37881/1.431
  32. Pathan A. Istradefylline: A new add-on drug to treat off episodes in adults with Parkinson’s disease. NeuroPharmac J. 2019; 4(2): 101-102. https://doi.org/10.37881/1.422
  33. Pathan A. Siponimod: A new approved oral drug to treat multiple sclerosis. NeuroPharmac J. 2019; 4(2): 99-100. https://doi.org/10.37881/1.421
  34. Pathan A. Stiripentol: New approved drug for the Dravet syndrome: Pharmacotherapeutics review. NeuroPharmac J. 2019; 4(1): 94-98. https://doi.org/10.37881/1.415
  35. Pathan A. Cannabidiol: FDA approved new drug for the Lennox-Gastaut syndrome and Dravet syndrome: Pharmacotherapeutics review. NeuroPharmac J. 2019; 4(1): 85-89. https://doi.org/10.37881/1.413
  36. Pathan A, Alshahrani A. FDA-approves the first therapy in 2018 for the seizures associated with Dravet syndrome. NeuroPharmac J. 2019; 4(1):81-84. https://doi.org/10.37881/1.412
  37. Pathan A, Almarshad F. Autism Spectrum Disorder: Medications overview. NeuroPharmac J. 2019; 4(1):77 80. https://doi.org/10.37881/1.411
  38. Alshahrani AM, Pathan A, Alruwais JF, Alduhayshi AM. Knowledge, attitude, and believes of epilepsy in local communities of Saudi Arabia. J Family Med Prim Care. 2019;8:1065-9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482760/
  39. Abdulaziz A. Alrashed, Khalid I. Aljammaz, Pathan A. Prevalence and risk factors of gastroesophageal reflux disease among Shaqra University students, Saudi Arabia.  J Family Med Prim Care. 2019;8:462-7. https://doi.org/10.4103/jfmpc.jfmpc_443_18
  40. Almarshad F, Ali A, Bakhsh E, Pathan A, Almegren A. Use of direct oral anticoagulants in daily practice. Am J Blood Res 2018;8(4):57-72. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334188/
  41. Pathan A, Alshahrani AM. Possible management of non-motor symptoms of Parkinson’s Disease. NeuroPharmac J. 2018; 3(3): 69-76. https://doi.org/10.37881/1.332
  42. Pathan A, Alshahrani AM. Gold Standard of Symptomatic treatment in Parkinson disease: Carbidopa / Levodopa. NeuroPharmac J. 2018; 3(3): 63-68. https://doi.org/10.37881/1.331
  43. Pathan A,  Alshahrani A. Neuroprotective effects of Valeriana wallichii on scopolamine induced learning & memory impairment in rats. Pharmacognosy Journal. 2018; 10(6)Suppl:s38-s41. http://doi.org/10.5530/pj.2018.6s.7
  44. Pathan A, Alshahrani AM. Alzheimer’s disease: Pharmacotherapy of subjective cognitive decline. NeuroPharmac Journal. 2018; 3(2): 57-62. https://doi.org/10.37881/1.321
  45. Pathan A, Alshahrani AM. Alzheimer’s disease: Pharmacotherapy of non-cognitive symptoms. NeuroPharmac Journal. 2018; 3(1): 47-50. https://doi.org/10.37881/1.311
  46. Pathan A. Essential Tremor: β blockers a first-line therapy. NeuroPharmac J. 2017; 2(3): A1-A2. https://doi.org/10.37881/1.231
  47. Pathan A, Gautam V. Phytochemical Investigations of Indigenous herb: Curcuma caesia rhizomes. NeuroPharmac Journal. 2017; 2(2): 41-46. https://doi.org/10.37881/1.221
  48. Pathan A. Zika Virus: A threat to global Public health- WHO Faramework Review. NeuroPharmac J. 2016; 1(1):28-31. https://doi.org/10.37881/1.117
  49. Pathan A. Anethum graveolens seeds: Neurological assessment of anxiolytic like effect on albino mice by using locomotor activity. NeuroPharmac J. 2016;1(1):25-27. https://doi.org/10.37881/1.116
  50. Pathan A. Neurological assessment of antidepressant effect of seeds of Anethum graveolens on albino mice. NeuroPharmac J. 2016;1(1):22-24. https://doi.org/10.37881/1.115
  51. Pathan A, Gautam V. Peganum harmala seeds: evaluation of antiasthmatic effect by using Clonidine induced mast cell degranulation. NeuroPharmac Journal. 2016; 1(01): 18-21. https://doi.org/10.37881/1.114
  52. Pathan A, Gautam V, M Sabu. Evaluation of Antiasthmatic effect of Curcuma zedoaria rhizomes by using milk induced leukocytosis in mice. NeuroPharmac Journal. 2016; 1(01): 13-17. https://doi.org/10.37881/1.113
  53. Pathan A, Gautam V, M Sabu. Curcuma caesia rhizomes: evaluation of antiasthmatic effect by using clonidine induced mast cell degranulation. NeuroPharmac Journal. 2016; 1 (01): 07-12. https://doi.org/10.37881/1.112
  54. Pathan A, Alshahrani A. In vivo Neurological assessment of serotonergic response of Coriandrum sativum seeds in mice. International Journal of Research in Pharmacology & Pharmacotherapeutics. 2015; 4(04): 399-405. http://www.ijrpp.com/user/download/215/IJRPP_15_409%20_399-405.pdf
  55. Pathan A, Alshahrani A, Almarshad F. Middle East Respiratory Syndrome Coronavirus (MERS Co-V): Threat to global Public Health & challenges. International Journal of Research in Pharmacy and Chemistry. 2015; 5 (03): 434-438. http://www.ijrpc.com/files/09-07-15/09-5106.pdf
  56. Pathan A, Alshahrani A, Almarshad F. Neurological assessment of seeds of Coriandrum sativum by using Antidepressant and Anxiolytic like activity on albino mice. Inventi Impact: Ethnopharmacology. 2015; 5 (03): 102-105. Click here
  57. Pathan A, Alshahrani A, Almarshad F. World Health Organization Survey on Health Status of Saudi Arabia: A Review. Inventi Impact: Pharmacy Practice. 2015; 5 (03): 102-104. Click here
  58. Pathan A, Alshahrani A, Almarshad F. Pharmacological Effect of Curcuma zedoaria rhizomes on milk induced eosinophilia in the management of asthma. International Journal of Ethnobiology and Ethnomedicine. 2015; 1(01): 01-05. Click here
  59. Pathan A, Alshahrani A, Almarshad F. Protective Effect of Tridax Procumbens Linn Potential in Ulcerative Colitis by using Myeloperoxidase activity in Albino rats. Inventi Rapid: Ethnopharmacology. 2015; 5(01): 01-04. Click here
  60. Gautam PV, Pathan A, AK Singhai. Estrogenic activity of Bauhinia racemosa extract in Female albino rats: An Investigational study. Pharmacognosy Journal. 2014; 6(06): 05-09. https://doi.org/10.5530/pj.2014.6.2
  61. Pathan A, Alshahrani A,  Almarshad F. Histopathological evaluation of Tridax procumbens Linn potential in ulcerative colitis. Inventi Rapid: Ethnopharmacology. 2015; 5 (01): 01-06. Click here
  62. Pathan A, Gautam V. Ethnopharmacological evaluation of Curcuma caesia in management of asthma. Inventi Rapid: Ethnopharmacology. 2014; 4 (04): 01-04. Click here
  63. Pathan A, Gautam V. Pharmacological Investigations of Curcuma caesia in management of asthma. Inventi Rapid: Ethnopharmacology. 2014; 4 (04): 01-04. Click here
  64. Gautam V, Pathan A, Bharti UK, AK Singhai. Hypolipidemic activity of Viscum articulatum extracts in albino mice. Inventi Rapid: Ethnopharmacology. 2013; 3 (04): 01-03. Click here
  65. Pathan A, Gautam V, M Sabu. Curcuma caesia almost untouched drug: An updated ethnopharmacological review. Inventi Rapid: Planta Activa. 2013; 3 (04): 01-04. Click here
  66. Gautam V, Pathan A, AK Singhai. Characterization of Indigenous Traditional Medicine -Muktashukti Bhasma. Indian Journal of Traditional Knowledge. 2013; 12(4): 483-488. http://www.niscair.res.in/sciencecommunication/researchjournals/rejour/ijtk/ijtk0.asp
  67. Gautam V, Pathan A, Bharti UK, AK Singhai. Comparative in vitro antibacterial activity of ethanolic extract of Plumbago zeylenica. Indian Drugs. 2013; 50(04): 53-55. https://www.indiandrugsonline.org/issuesarticle-details?id=Mjk2
  68. Gautam V, Pathan A, Bharti UK, AK Singhai. Abutilons Indicum Linn: A Phytopharmacological Review. International Journal of Research in Pharmacy and Chemistry. 2013; 3 (1): 153-156. http://www.ijrpc.com/files/24-331.pdf
  69. Gautam V, Pathan A, Bharti UK, AK Singhai. Diplocyclos palmatus: A Phytopharmacological Review. International Journal of Research in Pharmacy and Chemistry. 2013; 3 (1): 157-159. http://www.ijrpc.com/files/25-336.pdf
  70. Gautam V, Pathan A, AK Singhai, Bharti UK, JC Hundiwale, Anti-stress and anti-allergic effect of Actiniopteris radiata in some aspects of Asthma. Pakistan Journal of Pharmaceutical Sciences. 2013; 26 (01): 195-198. http://www.pjps.pk/wp-content/uploads/pdfs/CD-PJPS-26-1-13/Paper-29.pdf
  71. Pathan A, Gautam V. Solanum xanthocarpum (white variety): A Phytopharmacological Review. International Journal of Pharmacy and Technology. 2012; 4(04): 2305-2310. https://www.ijptonline.com/wp-content/uploads/2009/10/2305-2310.pdf
  72. Pathan A, Gautam V, AK Singhai, Bharti UK. Peganum harmala: A Phytopharmacological Review. Inventi Rapid: Planta Activa. 2012; 2 (04): 01-02. Click here
  73. Gautam V. AK Singhai, Pathan A. Pharmacognostical and Phytochemical studies of Viscum articulatum Inventi Rapid: Planta Activa. 2012; 2 (03): 01-05. Click here
  74. Kishor AK, Pathan A, Nadeem L. Evaluation of in-vitro anticancer activity of fruit Lagenaria siceraria against MCF7, HOP62 and DU145 cell lines. International Journal of Pharmacy and Technology. 2011; 4(01): 3909-3924. https://www.ijptonline.com/wp-content/uploads/2009/10/3909-3924.pdf
  75. Pathan A, Kishor AK, Nadeem L. Analgesic and Anxiolytic activity of seeds of Coriandrum sativum International Journal of Research in Pharmacy and Chemistry. 2011; 1(04): 1087-1099. http://www.ijrpc.com/files/000042.pdf
Copyright ©2021 all rights reserved
Designed by Author Gate Publications